Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend YieldsBenzinga • 3h
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research • Thursday
Gilead Sciences Pops On A New $4 Billion Opportunity In HIV PreventionInvestors Business Daily • 09/12/24
Gilead's Twice-Yearly Lenacapavir for HIV Prevention Reduced HIV Infections by 96% and Demonstrated Superiority to Daily Truvada® in Second Pivotal Phase 3 TrialBusiness Wire • 09/12/24
Gilead and Genesis Therapeutics Announce Strategic Collaboration to Discover and Develop Novel TherapiesBusiness Wire • 09/10/24
Undercovered Dozen: EPR Properties, Gilead, Portland General Electric, CNH Industrial +Seeking Alpha • 09/06/24
Gilead Sciences, Inc. (GILD) Wells Fargo 2024 Healthcare Conference (Transcript)Seeking Alpha • 09/06/24
Gilead Sciences, Inc. (GILD) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/06/24
Gilead to Present New Trodelvy® Data at the IASLC 2024 World Conference on Lung CancerBusiness Wire • 09/05/24
Merck's Death Cross Vs. Gilead's Golden Cross: Pharma Giants Diverge On Wall StreetBenzinga • 09/03/24
Avenzo Therapeutics Announces Clinical Study Collaboration with Gilead Sciences to Evaluate AVZO-021 and Trodelvy® in HR+/HER2- Metastatic Breast CancerBusiness Wire • 09/03/24
Ipsen's Iqirvo Shows Strong Start in Primary Biliary Cholangitis, Now Faces Rivalry from Gilead's LivdelziGlobeNewsWire • 08/29/24